about
Covalent Organic Frameworks: From Materials Design to Biomedical Application.Facile Access to Multisensitive and Self-Healing Hydrogels with Reversible and Dynamic Boronic Ester and Disulfide Linkages.Tumor Microenvironment Activated Membrane Fusogenic Liposome with Speedy Antibody and Doxorubicin Delivery for Synergistic Treatment of Metastatic Tumors.A Modular Coassembly Approach to All-In-One Multifunctional Nanoplatform for Synergistic Codelivery of Doxorubicin and Curcumin.Modulating the rigidity of nanoparticles for tumor penetrationGlutathione-induced amino-activatable micellar photosensitization platform for synergistic redox modulation and photodynamic therapyLiposomes-Camouflaged Redox-Responsive Nanogels to Resolve the Dilemma between Extracellular Stability and Intracellular Drug ReleaseLayer-by-layer zwitterionic modification of diverse substrates with durable anti-corrosion and anti-fouling propertiesSelf-assembly and self-delivery nanodrug of bortezomib: a simple approach to achieve the trade-off between functionality and druggabilityInjectable, Biodegradable, Thermosensitive Nanoparticles-Aggregated Hydrogel with Tumor-Specific Targeting, Penetration, and Release for Efficient Postsurgical Prevention of Tumor RecurrenceFacile Fabrication of Redox-Responsive Covalent Organic Framework Nanocarriers for Efficiently Loading and Delivering DoxorubicinRational Design of Nanoparticles to Overcome Poor Tumor Penetration and Hypoxia-Induced Chemotherapy Resistance: Combination of Optimizing Size and Self-Inducing High Level of Reactive Oxygen Species"Off/on" fluorescence imaging-guided cancer diagnosis and multi-modal therapyAn injectable and tumor-specific responsive hydrogel with tissue-adhesive and nanomedicine-releasing abilities for precise locoregional chemotherapy19F magnetic resonance imaging enabled real-time, non-invasive and precise localization and quantification of the degradation rate of hydrogel scaffolds in vivoAn injectable thermosensitive hydrogel self-supported by nanoparticles of PEGylated amino-modified PCL for enhanced local tumor chemotherapy
P50
Q47214325-2FD9EF71-D603-47A5-BDA8-301D70408DEDQ48097905-38BBD8EF-0FCE-4AF8-8701-1970A4805B38Q48185788-49EFA42F-1111-4E12-B07E-A712112BC1D8Q52654030-003AA410-58EB-4F26-BEFF-47A33E7E7C8AQ87984008-A5318DBD-3222-4214-8378-AB18486A230CQ88199678-D4FF10F9-4CDD-4ACB-96BE-88AA07F92FEFQ88586116-D2200177-D2A8-4A71-8A65-21D59D896D15Q90215639-6D4B943F-7DBF-4FBC-A6B5-FCD270741241Q91431700-CB79F6E0-4BAC-4FE1-AD4B-C1B2879EA2FCQ91877121-679B609B-B537-4C31-955A-D89B38359219Q92368697-ECFDC9FF-3FA9-47BC-8D9B-B2E6E81E00F8Q92471749-9DCCE9A0-9A65-4003-B34C-CDBB696057EFQ92794279-B31E7324-1786-449E-A889-DB8DEAC7B60AQ93077468-2B7011AB-BF17-45AE-B99D-A092899668C4Q94478864-EDE31D8A-673F-41C8-BEAC-B9CE2AA51054Q96305552-20EC224A-4005-4E47-AEB6-7C75F9C1C2BB
P50
description
researcher (ORCID 0000-0001-7833-9715)
@en
name
Jianhua Zhang
@en
type
label
Jianhua Zhang
@en
prefLabel
Jianhua Zhang
@en
P31
P496
0000-0001-7833-9715